Terms: = Leukemia AND NCKIPSD, AF3P21, 51517, ENSG00000213672, SPIN90, WASLBP, Q9NZQ3, WISH, ORF1
111 results:
1. Human neurotropic polyomavirus, JC virus, late coding region encodes a novel nuclear protein, ORF4, which targets the promyelocytic leukemia nuclear bodies (PML-NBs) and modulates their reorganization.
Saribas AS; Bellizzi A; Wollebo HS; Beer T; Tang HY; Safak M
Virology; 2023 Oct; 587():109866. PubMed ID: 37741199
[TBL] [Abstract] [Full Text] [Related]
2. Mucosal-associated invariant T cells in hematological malignancies: Current knowledge, pending questions.
Treiner E
Front Immunol; 2023; 14():1160943. PubMed ID: 37020559
[TBL] [Abstract] [Full Text] [Related]
3. Survey of understanding and awareness of fertility preservation in pediatric patients: Is conversation about fertility preservation unpleasant for pediatric patients?
Takae S; Iwahata Y; Sugishita Y; Iwahata H; Kanamori R; Shiraishi E; Ito K; Suzuki Y; Yamaya Y; Tanaka K; Oyama K; Keino D; Nakamura K; Odawara K; Horage Y; Meng L; Igualada A; Faizal AM; Aworet LO; Furuta S; Sakamoto M; Mori T; Kitagawa H; Suzuki N
Front Endocrinol (Lausanne); 2022; 13():1074603. PubMed ID: 36686445
[TBL] [Abstract] [Full Text] [Related]
4. Treatment of CML in pregnancy.
Robertson HF; Apperley JF
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):123-128. PubMed ID: 36485083
[TBL] [Abstract] [Full Text] [Related]
5. Severe pulmonary toxicity related to carfilzomib use: a rare but serious side effect.
Sridhar A; Yohannan B; Kachira JJ; Bhama S
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35787495
[TBL] [Abstract] [Full Text] [Related]
6. [Successful child delivery in treatment-free remission of chronic myeloid leukemia after discontinuation of dasatinib].
Hirose N; Fujisawa S; Sakuma T; Matsumura A; Miyashita K; Nakajima Y; Nakajima H
Rinsho Ketsueki; 2022; 63(2):114-116. PubMed ID: 35264501
[TBL] [Abstract] [Full Text] [Related]
7. Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel.
Pavlovsky C; Abello Polo V; Pagnano K; Varela AI; Agudelo C; Bianchini M; Boquimpani C; Centrone R; Conchon M; Delgado N; Funke V; Giere I; Luise I; Meillon L; Moiraghi B; Navarro JR; Pilleux L; Prado AI; Undurraga S; Cortes J
Blood Adv; 2021 Dec; 5(23):4855-4863. PubMed ID: 34438444
[TBL] [Abstract] [Full Text] [Related]
8. Parental adjustment following their child's completion of acute lymphoblastic leukemia treatment.
McCarthy MC; Marks IR; Mulraney M; Downie P; Matson A; De Luca CR
Pediatr Blood Cancer; 2021 Nov; 68(11):e29302. PubMed ID: 34411413
[TBL] [Abstract] [Full Text] [Related]
9. Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of
Huang Y; Yu SH; Zhen WX; Cheng T; Wang D; Lin JB; Wu YH; Wang YF; Chen Y; Shu LP; Wang Y; Sun XJ; Zhou Y; Yang F; Hsu CH; Xu PF
Theranostics; 2021; 11(14):6891-6904. PubMed ID: 34093860
[No Abstract] [Full Text] [Related]
10. Dhx15 regulates zebrafish definitive hematopoiesis through the unfolded protein response pathway.
Cai Y; Wang J; Jin D; Liu Q; Chen X; Pan L; Li Y; Wang X; Qian F; Wang J; Zhong TP; Wang S
Cancer Sci; 2021 Sep; 112(9):3884-3894. PubMed ID: 34077586
[TBL] [Abstract] [Full Text] [Related]
11. Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid leukemia: An Outcome of European leukemiaNet Project.
Yassin MA; Ghasoub RS; Aldapt MB; Abdulla MA; Chandra P; Shwaylia HM; Nashwan AJ; Kassem NA; Akiki SJ
Cancer Control; 2021; 28():10732748211009256. PubMed ID: 33874754
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Laboratory Validation and Implementation of Quantitative, Real-Time PCR-based Detection of NPM1 Type A Mutation.
Racchumi J; Tam W; Kluk MJ
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337831
[TBL] [Abstract] [Full Text] [Related]
13. Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience.
Assi R; Kantarjian H; Keating M; Pemmaraju N; Verstovsek S; Garcia-Manero G; Ravandi F; Borthakur G; Dahl J; Jabbour E; Cortes JE
Leuk Lymphoma; 2021 Apr; 62(4):909-917. PubMed ID: 33283580
[TBL] [Abstract] [Full Text] [Related]
14. Viral metagenomics reveals diverse anelloviruses in bone marrow specimens from hematologic patients.
Wang XC; Wang H; Tan SD; Yang SX; Shi XF; Zhang W
J Clin Virol; 2020 Nov; 132():104643. PubMed ID: 32961430
[TBL] [Abstract] [Full Text] [Related]
15. [Delivery of a Healthy Newborn by the Partner of a Patient with CML Undergoing Treatment with Nilotinib].
Aota Y; Udagawa S; Honda T; Okuda Y; Gotoh A
Gan To Kagaku Ryoho; 2020 May; 47(5):811-813. PubMed ID: 32408325
[TBL] [Abstract] [Full Text] [Related]
16. The Ban on US Government Funding Research Using Human Fetal Tissues: How Does This Fit with the NIH Mission to Advance Medical Science for the Benefit of the Citizenry?
McCune JM; Weissman IL
Stem Cell Reports; 2019 Nov; 13(5):777-786. PubMed ID: 31722191
[TBL] [Abstract] [Full Text] [Related]
17. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner.
Bogaert DJ; Laureys G; Naesens L; Mazure D; De Bruyne M; Hsu AP; Bordon V; Wouters E; Tavernier SJ; Lambrecht BN; De Baere E; Haerynck F; Kerre T
Br J Haematol; 2020 Mar; 188(5):768-773. PubMed ID: 31710708
[TBL] [Abstract] [Full Text] [Related]
18. [How to capture cytogenetic and molecular abnormalities into ProMISe database for hematological malignancies: Guidelines from the francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Raus N; Karam M; Chebel R; Dantin C; Pereira M; Wallart A; Yakoub-Agha I; Srour M
Bull Cancer; 2020 Jan; 107(1S):S52-S61. PubMed ID: 31615645
[TBL] [Abstract] [Full Text] [Related]
19. An evaluation of enasidenib for the treatment of acute myeloid leukemia.
Del Principe MI; Paterno G; Palmieri R; Maurillo L; Buccisano F; Venditti A
Expert Opin Pharmacother; 2019 Nov; 20(16):1935-1942. PubMed ID: 31454277
[No Abstract] [Full Text] [Related]
20. Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid leukemia Patients in Clinical Practice.
Almeida A; Pierdomenico F; Guerrero BP; Saraiva F; Montalvão A; Coutinho J; Mariz M; Melo T; Santos MJ; Pereira A; Cerveira N
Acta Med Port; 2019 Aug; 32(7-8):550-557. PubMed ID: 31445538
[TBL] [Abstract] [Full Text] [Related]
[Next]
